{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T03:31:47Z","timestamp":1789011107638,"version":"build-2803163510"},"reference-count":12,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2001,12,20]],"date-time":"2001-12-20T00:00:00Z","timestamp":1008806400000},"content-version":"vor","delay-in-days":322,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2001,2]]},"abstract":"<jats:p>Two patients with persistent disease after allografting for multiple myeloma received donor T\u2010cell lymphocyte infusion (DLI) (1\u00b75\u2003\u00d7\u200310<jats:sup>8<\/jats:sup> and 7\u2003\u00d7\u200310<jats:sup>7<\/jats:sup>) to induce a graft\u2010vs.\u2010myeloma effect for further tumour regression after withdrawal of immunosuppression. The interval between stem cell transplantation and DLI was 8 and 14\u2003months respectively. Both patients converted from partial to complete remission, lasting 12+ and 28+ months. Immunofixation became negative after 3 and 4\u2003months. The main toxicity was grade II and III acute graft\u2010vs.\u2010host disease (GvHD) and limited or extensive chronic GvHD in each patient. We conclude that DLI induced further tumour reduction in patients with persistent disease after allografting for multiple myeloma.<\/jats:p>","DOI":"10.1046\/j.1365-2141.2001.02599.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T06:31:08Z","timestamp":1047364268000},"page":"421-423","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Donor lymphocyte infusion enhances remission status in patients with persistent disease after allografting for multiple myeloma"],"prefix":"10.1111","volume":"112","author":[{"given":"Nicolaus","family":"Kr\u00f6ger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Kr\u00fcger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmut","family":"Renges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatjana","family":"Zabelina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Stute","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Wittkowsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf","family":"Kuse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel Rolf","family":"Zander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2001,12,20]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"crossref","first-page":"4711","DOI":"10.1182\/blood.V88.12.4711.bloodjournal88124711","article-title":"Allogeneic bone marrow transplantation versus autologous stem cell transplantation in multiple myeloma: a retrospective case matched study from the European Group for Blood and Marrow Transplantation","volume":"88","author":"Bj\u00f6rkstrand B.","year":"1996","journal-title":"Blood"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1701403"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1997.15.2.433"},{"key":"e_1_2_6_5_1","doi-asserted-by":"crossref","first-page":"4337","DOI":"10.1182\/blood.V86.11.4337.bloodjournal86114337","article-title":"CD8 depleted donor lymphocyte infusion as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation","volume":"86","author":"Giralt S.","year":"1995","journal-title":"Blood"},{"key":"e_1_2_6_6_1","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1182\/blood.V86.5.2041.bloodjournal8652041","article-title":"Graft versus leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia","volume":"86","author":"Kolb H.J.","year":"1995","journal-title":"Blood"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.16.3031"},{"key":"e_1_2_6_8_1","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1182\/blood.V86.4.1261.bloodjournal8641261","article-title":"Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia following bone marrow transplantation: separation of graft versus leukemia responses from graft versus host disease","volume":"86","author":"Mackinnon S.","year":"1995","journal-title":"Blood"},{"key":"e_1_2_6_9_1","first-page":"381","article-title":"T cell depleted allogeneic bone marrow transplantation in a child with recurrent multiple extramedullary plasmocytomas","volume":"10","author":"Or R.","year":"1992","journal-title":"Bone Marrow Transplantation"},{"key":"e_1_2_6_10_1","first-page":"825","article-title":"1994 Consensus Conference on acute GvHD\u2010grading","volume":"15","author":"Przepiorka K.M.","year":"1995","journal-title":"Bone Marrow Transplantatation"},{"key":"e_1_2_6_11_1","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1182\/blood.V84.4.1333.1333","article-title":"Gangiclovir treatment of herpes simplex thymidine kinase transduced primary T\u2010lymphocytes: an approach for specific in vivo donor T\u2010cell depletion after bone marrow transplantation?","volume":"84","author":"Tiberghien P.","year":"1994","journal-title":"Blood"},{"key":"e_1_2_6_12_1","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1182\/blood.V87.3.1196.bloodjournal8731196","article-title":"Graft versus myeloma effect: proof of a principle","volume":"87","author":"Tricot G.","year":"1996","journal-title":"Blood"},{"key":"e_1_2_6_13_1","doi-asserted-by":"crossref","unstructured":"Verdonck L.F. Lokhorst H.M. Dekker A.W. Nieuwenhuis H.K.&Petersen E.J.(1996)Graft versus myeloma effect in two cases.Lancet 347 800\u2013801.","DOI":"10.1016\/S0140-6736(96)90871-5"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2001.02599.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2001.02599.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2141.2001.02599.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T22:11:02Z","timestamp":1697580662000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2141.2001.02599.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,2]]},"references-count":12,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2001,2]]}},"alternative-id":["10.1046\/j.1365-2141.2001.02599.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2141.2001.02599.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,2]]},"assertion":[{"value":"2001-12-20","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}